We are live on ! Find out more
CGIM

Capital Group Investment Management Portfolio holdings

AUM $585M
1-Year Est. Return 31.36%
This Fund
S&P 500
This Quarter Est. Return
-3.35%
1 Year Est. Return
+31.36%
3 Year Est. Return
+120.23%
5 Year Est. Return
10 Year Est. Return
AUM
$585M
AUM Growth
-$30.9M
Cap. Flow
+$10.6M
Cap. Flow %
1.81%
Top 10 Hldgs %
36.6%
Holding
150
New
11
Increased
61
Reduced
45
Closed
10

Top Sells

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$5.05M
2
FLUT icon
Flutter Entertainment
FLUT
+$3.69M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.85M
4
CB icon
Chubb
CB
+$2.81M
5
AVGO icon
Broadcom
AVGO
+$2.71M

Sector Composition

Rank Sector Weight
1 Technology 24.06%
2 Healthcare 16.29%
3 Consumer Discretionary 15.05%
4 Communication Services 12.59%
5 Industrials 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
101
Coca-Cola
KO
$354B
$1.26M 0.21%
16,520
RACE icon
102
Ferrari
RACE
$63.3B
$1.18M 0.2%
3,497
+2,588
+285% +$905K
ECL icon
103
Ecolab
ECL
$75.6B
$1.18M 0.2%
4,435
-9,156
-67% -$2.58M
BRK.B icon
104
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.08M 0.19%
2,261
ILMN icon
105
Illumina
ILMN
$29.4B
$1.06M 0.18%
8,594
-3,235
-27% -$425K
SRE icon
106
Sempra
SRE
$60.8B
$1.04M 0.18%
10,665
-3,845
-26% -$352K
DAL icon
107
Delta Air Lines
DAL
$55.9B
$1.03M 0.18%
15,526
CME icon
108
CME Group
CME
$92.2B
$910K 0.16%
3,082
WLK icon
109
Westlake Corp
WLK
$9.46B
$899K 0.15%
+7,693
New +$746K
XPO icon
110
XPO
XPO
$25B
$829K 0.14%
4,261
-1,517
-26% -$272K
ARM icon
111
Arm
ARM
$278B
$829K 0.14%
5,478
EFX icon
112
Equifax
EFX
$20.3B
$804K 0.14%
4,465
-1,255
-22% -$249K
BMY icon
113
Bristol-Myers Squibb
BMY
$127B
$796K 0.14%
13,127
+932
+8% +$54.3K
TT icon
114
Trane Technologies
TT
$106B
$786K 0.13%
1,885
+110
+6% +$46.7K
TTEK icon
115
Tetra Tech
TTEK
$8.23B
$780K 0.13%
25,906
MDB icon
116
MongoDB
MDB
$24B
$746K 0.13%
3,049
AKAM icon
117
Akamai
AKAM
$16.8B
$716K 0.12%
+6,235
New +$625K
CM icon
118
Canadian Imperial Bank of Commerce
CM
$107B
$709K 0.12%
7,504
-6,707
-47% -$641K
CRH icon
119
CRH
CRH
$66.7B
$698K 0.12%
6,644
RTX icon
120
RTX Corp
RTX
$287B
$696K 0.12%
+3,609
New +$718K
INTC icon
121
Intel
INTC
$466B
$674K 0.12%
15,265
-15,744
-51% -$722K
AXP icon
122
American Express
AXP
$223B
$667K 0.11%
2,204
ASND icon
123
Ascendis Pharma A/S
ASND
$16.7B
$665K 0.11%
2,906
GRFS
124
Grifois
GRFS
$5.16B
$657K 0.11%
81,955
FCX icon
125
Freeport-McMoran
FCX
$90B
$640K 0.11%
10,885
-22,186
-67% -$1.34M

Similar funds

Capital Group Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, Capital Group Investment Management held 150 positions worth $585M, down 5% from $616M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Capital Group Investment Management's Q1 2026 filing shows 11 new, 61 increased, 45 reduced and 10 closed positions. Its largest new stake was AstraZeneca: 99,013 shares worth $19.3M. The largest sale was Synopsys, an estimated $5.05M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital Group Investment Management's largest Q1 2026 buy was AstraZeneca: 99,013 shares worth $19.3M.
  • Capital Group Investment Management added most to NVIDIA in Q1 2026, an estimated $4.93M increase.
  • Capital Group Investment Management's biggest Q1 2026 reduction was Alnylam Pharmaceuticals, cutting an estimated $2.85M.
  • Capital Group Investment Management fully exited Synopsys in Q1 2026, selling an estimated $5.05M.
  • Capital Group Investment Management's ten largest holdings make up 37% of its $585M portfolio in Q1 2026.
  • Capital Group Investment Management opened 11 new positions and closed 10 in Q1 2026.
  • Capital Group Investment Management's portfolio value fell 5% quarter-over-quarter to $585M.

Based on Capital Group Investment Management's 13F filing for Q1 2026, filed 13 May 2026.